Reviva Pharmaceuticals Holdings, Inc.Reviva Pharmaceuticals Holdings, Inc.Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

No trades
See on Supercharts

Price target

15.200.000.00%
The 5 analysts offering 1 year price forecasts for RVPH have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to RVPH in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RVPH EPS for the last quarter is −0.26 USD despite the estimation of −0.30 USD. In the next quarter EPS is expected to reach −0.25 USD. Track more of Reviva Pharmaceuticals Holdings, Inc. financials and stay on top of what is up with the company.
In the next quarter Reviva Pharmaceuticals Holdings, Inc. revenue is expected to reach 0.00 USD. Check out Reviva Pharmaceuticals Holdings, Inc. revenue and earnings and make informed decisions.
According to analysts, RVPH price target is 15.20 USD with a max estimate of 17.00 USD and a min estimate of 14.00 USD. Check if this forecast comes true in a year, meanwhile watch Reviva Pharmaceuticals Holdings, Inc. stock price chart and keep track of the current situation with RVPH news and stock market news.
We've gathered opinions of 5 analysts rating RVPH stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.